Literature DB >> 18007595

Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau.

Tetsuya Kimura1, Shunji Yamashita, Tetsuya Fukuda, Jun-Mi Park, Miyuki Murayama, Tatsuya Mizoroki, Yuji Yoshiike, Naruhiko Sahara, Akihiko Takashima.   

Abstract

To investigate how tau affects neuronal function during neurofibrillary tangle (NFT) formation, we examined the behavior, neural activity, and neuropathology of mice expressing wild-type human tau. Here, we demonstrate that aged (>20 months old) mice display impaired place learning and memory, even though they do not form NFTs or display neuronal loss. However, soluble hyperphosphorylated tau and synapse loss were found in the same regions. Mn-enhanced MRI showed that the activity of the parahippocampal area is strongly correlated with the decline of memory as assessed by the Morris water maze. Taken together, the accumulation of hyperphosphorylated tau and synapse loss in aged mice, leading to inhibition of neural activity in parahippocampal areas, including the entorhinal cortex, may underlie place learning impairment. Thus, the accumulation of hyperphosphorylated tau that occurs before NFT formation in entorhinal cortex may contribute to the memory problems seen in Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007595      PMCID: PMC2140104          DOI: 10.1038/sj.emboj.7601917

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  Age differences in prefrontal cortical activity in working memory.

Authors:  B Rypma; V Prabhakaran; J E Desmond; J D Gabrieli
Journal:  Psychol Aging       Date:  2001-09

2.  Single-molecule investigation of the interference between kinesin, tau and MAP2c.

Authors:  Arne Seitz; Hiroaki Kojima; Kazuhiro Oiwa; Eva-Maria Mandelkow; Young-Hwa Song; Eckhard Mandelkow
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau.

Authors:  Kentaro Tanemura; Miyuki Murayama; Takumi Akagi; Tsutomu Hashikawa; Takashi Tominaga; Michinori Ichikawa; Haruyasu Yamaguchi; Akihiko Takashima
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

4.  Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.

Authors:  K Tanemura; T Akagi; M Murayama; N Kikuchi; O Murayama; T Hashikawa; Y Yoshiike; J M Park; K Matsuda; S Nakao; X Sun; S Sato; H Yamaguchi; A Takashima
Journal:  Neurobiol Dis       Date:  2001-12       Impact factor: 5.996

5.  Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation.

Authors:  R Lalonde; M Dumont; M Staufenbiel; C Sturchler-Pierrat; C Strazielle
Journal:  Brain Res       Date:  2002-11-22       Impact factor: 3.252

Review 6.  OsiriX: an open-source software for navigating in multidimensional DICOM images.

Authors:  Antoine Rosset; Luca Spadola; Osman Ratib
Journal:  J Digit Imaging       Date:  2004-06-29       Impact factor: 4.056

7.  Age-dependent cognitive decline in the APP23 model precedes amyloid deposition.

Authors:  Debby Van Dam; Rudi D'Hooge; Matthias Staufenbiel; Chris Van Ginneken; Frans Van Meir; Peter P De Deyn
Journal:  Eur J Neurosci       Date:  2003-01       Impact factor: 3.386

8.  Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.

Authors:  Yoshitaka Tatebayashi; Tomohiro Miyasaka; De-Hua Chui; Takumi Akagi; Ken-ichi Mishima; Katsunori Iwasaki; Michihiro Fujiwara; Kentaro Tanemura; Miyuki Murayama; Koichi Ishiguro; Emmanuel Planel; Shinji Sato; Tsutomu Hashikawa; Akihiko Takashima
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

9.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.

Authors:  K Stamer; R Vogel; E Thies; E Mandelkow; E-M Mandelkow
Journal:  J Cell Biol       Date:  2002-03-18       Impact factor: 10.539

10.  Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease.

Authors:  A Ebneth; R Godemann; K Stamer; S Illenberger; B Trinczek; E Mandelkow
Journal:  J Cell Biol       Date:  1998-11-02       Impact factor: 10.539

View more
  70 in total

1.  Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function.

Authors:  Erica Peethumnongsin; Li Yang; Verena Kallhoff-Muñoz; Lingyun Hu; Akihiko Takashima; Robia G Pautler; Hui Zheng
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss.

Authors:  Tetsuya Kimura; Tetsuya Fukuda; Naruhiko Sahara; Shunji Yamashita; Miyuki Murayama; Tatsuya Mizoroki; Yuji Yoshiike; Boyoung Lee; Ioannis Sotiropoulos; Sumihiro Maeda; Akihiko Takashima
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

3.  Cognitive decline is associated with reduced reelin expression in the entorhinal cortex of aged rats.

Authors:  Alexis M Stranahan; Rebecca P Haberman; Michela Gallagher
Journal:  Cereb Cortex       Date:  2010-06-10       Impact factor: 5.357

4.  Amyloid precursor protein and tau transgenic models of Alzheimer's disease: insights from the past and directions for the future.

Authors:  Naruhiko Sahara; Jada Lewis
Journal:  Future Neurol       Date:  2010-05-01

5.  Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.

Authors:  Atsuko Kubo; Shouyou Ueda; Ayaka Yamane; Satoko Wada-Kakuda; Mai Narita; Makoto Matsuyama; Akane Nomori; Akihiko Takashima; Taisuke Kato; Osamu Onodera; Motohito Goto; Mamoru Ito; Takami Tomiyama; Hiroshi Mori; Shigeo Murayama; Yasuo Ihara; Hiroaki Misonou; Tomohiro Miyasaka
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

6.  Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

Authors:  Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant
Journal:  FASEB J       Date:  2011-08-09       Impact factor: 5.191

7.  Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young mice.

Authors:  Guorong Tao; Jie Zhang; Lei Zhang; Yuanlin Dong; Buwei Yu; Gregory Crosby; Deborah J Culley; Yiying Zhang; Zhongcong Xie
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

8.  Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.

Authors:  Zhi Tang; Erika Bereczki; Haiyan Zhang; Shan Wang; Chunxia Li; Xinying Ji; Rui M Branca; Janne Lehtiö; Zhizhong Guan; Peter Filipcik; Shaohua Xu; Bengt Winblad; Jin-Jing Pei
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

Review 9.  Why pleiotropic interventions are needed for Alzheimer's disease.

Authors:  Sally A Frautschy; Greg M Cole
Journal:  Mol Neurobiol       Date:  2010-05-02       Impact factor: 5.590

10.  In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?

Authors:  Benoît Delatour; Stéphane Epelbaum; Alexandra Petiet; Marc Dhenain
Journal:  Int J Alzheimers Dis       Date:  2010-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.